Sopharma AD operates in the Drug stores and proprietary stores sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sopharma AD with three other
drug stores in Europe:
Georgia Healthcare Group PLC
of the United Kingdom
sales of £251.04 million [US$328.59 million]
of which 61%
Aptechnaya set' 36,6' PAO
(44.66 billion Russian Rubles [US$723.11 million]
of which 100%
was Pharmaceuticals), and
Shop Apotheke Europe NV
based in Germany
(539.71 million Euro [US$595.70 million]
of which 91%
Sopharma AD reported sales of 1.19 billion Bulgarian Lev (US$671.60 million)
December of 2018.
increase of 16.0%
versus 2017, when the company's sales were 1.03 billion Bulgarian Lev.
Sales of Distribution of Pharmaceutical Products saw an increase
22.7% in 2018, from
757.98 million Bulgarian Lev to 929.83 million Bulgarian Lev.
Not all segments of Sopharma AD experienced an increase in sales in 2018:
sales of Production of Pharmaceutical Products fell 4.5% to 231.92 million Bulgarian Lev.